Tissue Homogenate VEGF Levels in Malignant Salivary Gland Tumors vs. Controls: An Exploratory Pilot Study
Journal of Clinical Medicine · 12.06.2026 · 15 (12) · 4557
DOI: 10.3390/jcm15124557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.06.2026. Verfasst von Wojciech Domka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Collegium Medicum, Faculty of Medicine, University of Rzeszów, 35-959 Rzeszów, Poland. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Tumors of the salivary glands represent a rare and heterogeneous group of tumors, the diagnosis and treatment of which present significant clinical challenges. One of the key processes affecting the progression of these tumors is angiogenesis, in which vascular endothelial growth factor (VEGF) and its receptors play a fundamental role. The aim of the present study was to assess differences in VEGF levels in salivary gland tumor tissue compared with normal salivary gland tissue.
Methods
Salivary gland tissue samples were obtained by surgical resection. Thirteen patients were included in the study, nine with malignant lesions and four patients with normal salivary gland tissue as controls. After tissue homogenization, VEGF concentration was analyzed by a chemiluminescent ELISA (Human VEGF QuantiGlo ELISA Kit, QVE00B; R&D Systems, Minneapolis, MN, USA).
Results
VEGF concentrations in salivary gland tumor tissue homogenate supernatants showed a higher central tendency than controls, but the between-group difference did not reach statistical significance (Mann–Whitney U test, p = 0.199; Welch’s t-test as sensitivity analysis, p = 0.102).
Conclusions
VEGF quantification in salivary gland tissue homogenate supernatants was feasible and showed substantial inter-individual variability with partial overlap between tumors and controls. Although tumors showed higher central tendency, the differences were not statistically significant in this small cohort; therefore, the findings are hypothesis-generating and do not support diagnostic or prognostic claims.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Collegium Medicum, Faculty of Medicine, University of Rzeszów, 35-959 Rzeszów, Poland.
- Department of Otorhinolaryngology and Oncological Laryngology in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
- Department of Biochemistry and General Chemistry, Collegium Medicum, Faculty of Medicine, University of Rzeszów, 35-959 Rzeszów, Poland.
- Doctoral School of University of Rzeszów, Collegium Medicum, Faculty of Medicine, University of Rzeszów, 35-959 Rzeszów, Poland.
- Department of Photomedicine and Physical Chemistry, Faculty of Medicine, University of Rzeszów, 35-959 Rzeszów, Poland.
ORCID-Profile: Tomasz Kubrak, Angelika Myśliwiec, Agnieszka Przygórzewska, Dorota Bartusik-Aebisher, David Aebisher
Zitieren
APA
Domka, W., Misiołek, M., Kubrak, T., Myśliwiec, A., Przygórzewska, A., Bartusik-Aebisher, D., & Aebisher, D. (2026). Tissue Homogenate VEGF Levels in Malignant Salivary Gland Tumors vs. Controls: An Exploratory Pilot Study. Journal of Clinical Medicine, 15(12), 4557. https://doi.org/10.3390/jcm15124557
Vancouver
Domka W, Misiołek M, Kubrak T, Myśliwiec A, Przygórzewska A, Bartusik-Aebisher D, et al. Tissue Homogenate VEGF Levels in Malignant Salivary Gland Tumors vs. Controls: An Exploratory Pilot Study. Journal of Clinical Medicine. 2026;15(12):4557. doi:10.3390/jcm15124557
BibTeX
@article{Domka2026,
author = {Domka, Wojciech and Misiołek, Maciej and Kubrak, Tomasz and Myśliwiec, Angelika and Przygórzewska, Agnieszka and Bartusik-Aebisher, Dorota and Aebisher, David},
title = {Tissue Homogenate VEGF Levels in Malignant Salivary Gland Tumors vs. Controls: An Exploratory Pilot Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4557},
doi = {10.3390/jcm15124557}
}
EUVIMED